VHL and neoplasm: PBRM1 truncating mutations are found in up to 41% of cases, making it the second most commonly mutated gene after VHL [102], while BAP1 and SETD2 mutations are associated with aggressive histological features, higher tumor grades, and poorer survival outcomes [103,104].